Insmed (INSM) Current Assets (2010 - 2026)
Insmed (INSM) recorded quarterly Current Assets of $1.6 billion in Q1 2026, down 10.09% quarter-over-quarter from $1.8 billion in Q4 2025, and up 15.01% on a YoY basis from $1.4 billion in Q1 2025.
Insmed (INSM) Current Assets (2010 - 2026) Analysis & Trends
Insmed's Current Assets history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- In Q1 2026, Current Assets rose 15.01% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 15.01% YoY), while the FY2025 annual figure was $1.8 billion, up 10.64% from the prior year.
- Current Assets was $1.6 billion for Q1 2026 at Insmed, down from $1.8 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $2.1 billion in Q2 2025 to a low of $632.2 million in Q3 2022.
- Historically, Current Assets has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
- The sharpest annual moves came in 2022 and 2025: Current Assets slumped 35.01% in 2022, then surged 84.88% in 2025.
- A 5-year view of Current Assets shows it stood at $1.3 billion in 2022, then dropped by 27.04% to $929.1 million in 2023, then jumped by 74.55% to $1.6 billion in 2024, then climbed by 10.64% to $1.8 billion in 2025, then fell by 10.09% to $1.6 billion in 2026.
- The last three Current Assets figures came in at $1.6 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 1.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 1.40 Bn |
| Dec 31, 2024 | 1.62 Bn |
| Sep 30, 2024 | 1.65 Bn |
| Jun 30, 2024 | 1.42 Bn |
| Mar 31, 2024 | 758.72 Mn |
| Dec 31, 2023 | 929.06 Mn |
| Sep 30, 2023 | 926.58 Mn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 632.17 Mn |
| Jun 30, 2022 | 674.73 Mn |
| Mar 31, 2022 | 756.14 Mn |
| Dec 31, 2021 | 837.04 Mn |
| Sep 30, 2021 | 958.98 Mn |
| Jun 30, 2021 | 1.04 Bn |